Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Positive Interim Efficacy Data from GDC-0084 Phase II Study in Glioblastoma Released at SNO Conference

En-CPhI.CNNovember 26, 2019

Tag: GDC-0084 , glioblastoma , Kazia

PharmaSources Customer Service